(Q33501101)

27 July 2017

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer (English)

1 reference

27 July 2017

1 reference

1 reference

1 reference

D Cunningham

3

0 references

author name string

P Ross

1

1 reference

27 July 2017

A Norman

2

1 reference

27 July 2017

A Webb

4

1 reference

27 July 2017

T Iveson

5

1 reference

27 July 2017

A Padhani

6

1 reference

27 July 2017

J Prendiville

7

1 reference

27 July 2017

M Watson

8

1 reference

27 July 2017

A Massey

9

1 reference

27 July 2017

R Popescu

10

1 reference

27 July 2017

J Oates

11

1 reference

27 July 2017

1 October 1997

1 reference

27 July 2017

1 reference

27 July 2017

8

1 reference

27 July 2017

10

1 reference

27 July 2017

995-1001

1 reference

Chemotherapy for metastatic colorectal cancer

27 July 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Clinical experience with mitomycin C in large infrequent doses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Time-dependent interactions between 5-fluorouracil and mitomycin C on a human colon carcinoma cell line, HCT-8, in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Mitomycin-C alone and in combination with infused 5-fluorouracil in the treatment of disseminated gastrointestinal carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008263516099

7 January 2021

Identifiers

DOI

10.1023/A:1008263516099

1 reference

27 July 2017

1 reference